Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D08XKL
|
|||
| Former ID |
DIB013558
|
|||
| Drug Name |
SPI-014
|
|||
| Synonyms |
SPI-1802; SPI-1810; Amyloid beta peptide 1-42 deposition inhibitor (AD), Satori; Gamma-secretase modulators (Alzheimers disease), Satori Pharmaceuticals
Click to Show/Hide
|
|||
| Indication | Alzheimer disease [ICD-11: 8A20; ICD-10: G30, G30.9; ICD-9: 331] | Phase 1 | [1] | |
| Hypophosphatasia [ICD-11: 5C64.3; ICD-10: E83.3; ICD-9: 275.3] | Phase 1 | [1] | ||
| Company |
Satori Pharmaceuticals Inc
|
|||
| Structure |
 |
Download2D MOL
|
||
| Formula |
CLa2O5
|
|||
| Canonical SMILES |
C(=O)([O-])[O-].[O-2].[O-2].[La+3].[La+3]
|
|||
| InChI |
1S/CH2O3.2La.2O/c2-1(3)4;;;;/h(H2,2,3,4);;;;/q;2*+3;2*-2/p-2
|
|||
| InChIKey |
VMVUIGXLELJYAZ-UHFFFAOYSA-L
|
|||
| CAS Number |
CAS 1347739-77-8
|
|||
| PubChem Compound ID | ||||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | ClinicalTrials.gov (NCT01560884) Study to Assess the Safety and the Phosphate Binding Capacity of Renazorb. U.S. National Institutes of Health. | |||
| REF 2 | Modulation of gamma-secretase for the treatment of Alzheimer's disease. Int J Alzheimers Dis. 2012;2012:210756. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.